key: cord-0790961-rk6h1vka authors: McCoy, John; Wambier, Carlos G.; Vano‐Galvan, Sergio; Shapiro, Jerry; Sinclair, Rodney; Müller Ramos, Paulo; Washenik, Kenneth; Andrade, Murilo; Herrera, Sabina; Goren, Andy title: Racial Variations in COVID‐19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti‐Androgens a Potential Treatment for COVID‐19? date: 2020-04-25 journal: J Cosmet Dermatol DOI: 10.1111/jocd.13455 sha: 8bbf9b292154a25bc810b440ff5492c1eebe5e98 doc_id: 790961 cord_uid: rk6h1vka Racial disparities in COVID‐19 infection rates and disease severity are due to a multifactorial etiology that can include socioeconomic as well as other factors. Nevertheless, genetic factors in different ethnic groups often contribute to disease severity and treatment response. In particular, the frequency of genetic variations in the androgen receptor differs by ethnicity and gender. For example, the increased prevalence of prostate cancer and androgenetic alopecia among African Americans correlates with the frequency of these variants. In this communication, we propose that androgens may be implicated in COVID‐19 disease severity. As such, special attention may need to be given to African Americans infected by the SARS‐CoV‐2 virus. Finally, if a link to genetic variations in the androgen receptor and COVID‐19 disease severity can be established, it would suggest new treatment options. Racial disparities in COVID-19 infection rates and disease severity are due to a multifactorial etiology that can include socioeconomic as well as other factors. Nevertheless, genetic factors in different ethnic groups often contribute to disease severity and treatment response. In particular, the frequency of genetic variations in the androgen receptor differs by ethnicity and gender. For example, the increased prevalence of prostate cancer and androgenetic alopecia among African Americans correlates with the frequency of these variants. In this communication, we propose that androgens may be implicated in COVID-19 disease severity. As such, special attention may need to be given to African Americans infected by the SARS-CoV-2 virus. Finally, if a link to genetic variations in the androgen receptor and COVID-19 disease severity can be established, it would suggest new treatment options. As the SARS-CoV-2 (COVID-19) pandemic continues to infect many more Americans, a racial disparity in the number of deaths from infection has emerged. On April 7 th , 2020 the Washington Post reported that counties with census demographics indicating a majority black population had almost six times the rate of death from COVID-19 as counties where the majority of residents were white. 1 In the report, the deaths per hundred thousand residences for counties consisting of a majority white, Asian, black and Hispanic populations was 1.1, 0.4, 6.3, and 0.6, respectively. There is undoubtedly a multifactorial etiology to this racial disparity that can include socioeconomic as well as other factors. However, a similar racial bifurcation is evident in conditions influenced by sensitivity to androgens, e.g., prostate cancer and androgenetic alopecia. 2,3 Further, gender and age differences in the severity of COVID-19 disease and mortality rates have also been reported 4 and might also be explained by an androgen-mediated mechanism. We have recently published two communications offering an explanation for a gender disparity in COVID-19 disease severity. 5,6 SARS-CoV-2 enters type II pneumocytes by binding to angiotensin-converting enzyme 2 (ACE2). Binding of SARS-CoV-2 to ACE2 is mediated by proteolytic cleavage of a viral surface protein by transmembrane protease, serine 2 (TMPRSS2). [7] [8] [9] As such, concentrations and activity of both ACE2 and TMPRSS2 in host pneumocytes are crucial to SARS-CoV-2 ability to infect a host. Both ACE2 and TMPRSS2 are regulated by the androgen receptor; in fact, the 15 base pair androgen response element is the only known transcription promoter for the TMPRSS2 gene. [10] [11] [12] [13] Androgen mediated expression of ACE2 and TMPRSS2 may explain the gender difference in COVID-19 disease severity and mortality. Racial variations in other androgen-mediated conditions have been noted. For example, it has been reported that African American men are at higher risk for aggressive prostate cancer. 2 Polymorphisms in the length of CAG repeat in exon 1 of the androgen receptor have been shown to correlate with incidence of prostate cancer. 14 In a study of men without prostate cancer, Sator et al. reported that average CAG repeat length for non-Hispanic white men (n= 130) was 21.0, while the average CAG repeat length for African American men (n=65) was 19.0. 15 In a study of men with prostate cancer, Bennett et al. reported a CAG length of 21.9 in non-Hispanic white men (n= 168) and 19.8 in African American men (n=151). Additionally, it was found that the occurrence of stage D prostate cancer (currently classified as High Risk) was highest in men with shorter CAG repeats. 16 Racial variations in androgenetic alopecia (AGA) have also been reported to correlate with CAG length polymorphisms in the androgen receptor. 3 Finally, while no direct association between CAG repeat length in the AR gene and SARS-CoV-2 viral infectivity has been reported, studies in animal models demonstrated the effect of androgens (testosterone) on influenza disease severity. 17 In males, testosterone's biological action is dependent on the length of the CAG repeat of the AR gene. Currently our group is planning a clinical study to measure CAG length polymorphisms in patients hospitalized with COVID-19 infection. While a direct link between polymorphisms in the androgen receptor and COVID-19 disease severity has not been established, we believe that the similarities in racial and gender bias to other androgenmediated conditions is noteworthy. If androgen sensitivity can be confirmed as a predisposition to SARS-Cov-2 disease severity, it could suggest the use of anti-androgens or androgen modulating drugs as a means of treatment, either alone or combined with a TMPRSS2 inhibitors. For example, anti-androgens like bicalutamide and enzalutamide, or androgen modulators like finasteride and dutasteride may be beneficial. African Americans are at higher risk of death from coronavirus -The Washington Post Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men Polymorphism of the androgen receptor gene is associated with male pattern baldness Clinical Characteristics of Coronavirus Disease 2019 in China What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy A preliminary observation: male pattern hair loss among hospitalized COVID-19 patients in Spain -a potential clue to the role of androgens in COVID-19 severity Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis National Institutes of Health. TMPRSS2 transmembrane serine protease 2 Prostate-localized and androgen-regulated This article is protected by copyright. All rights reserved expression of the membrane-bound serine protease TMPRSS2 Sex hormones promote opposite effects on ACE and ACE2 activity, hypertrophy and cardiac contractility in spontaneously hypertensive rats Influence of CAG repeat polymorphism on the targets of testosterone action Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer Racial Variation in CAG Repeat Lengths Within the Androgen Receptor Gene Among Prostate Cancer Patients of Lower Socioeconomic Status Age and testosterone mediate influenza pathogenesis in male mice